| |
| Topical
anti inflammatory for mastitis with added benefits |
|
|
|
| |
|
 |
Presentation: Wisprec
spray is available in 200 ml. vertical
spray can. |
|
| |
|
|
| Composition: |
|
|
| |
|
|
| Wisprec Spray contains the extracts
of : |
| |
|
|
| Ingredient |
Marker
Compound |
Pharmacological
Action |
| |
|
|
| Tulasi |
Triterpenoids
(Ursolic acid, oleanolic acid) Phenolics(,Roasmarinic
acid, eugenol) |
Anti
bacterial,
Anti inflammatory
|
| Bhutika |
Citral |
Anti-bacterial |
| Haridra |
Curcumin |
Anti-inflammatory,
Anti bacterial |
|
| |
|
|
| Field Trials: |
|
| |
|
|
| The invitro efficacy of WISPREC
against various pathogenic species of bacteria
was evaluated and interpreted based on absence
of growth at minimum concentration of drug in
the agar |
| |
|
[ Read
more ...] |
| |
|
|
| Features & Benefits
: |
|
| |
|
|
| Features |
Benefits |
| |
|
| Anti
– inflammatory property |
Acts
as a best adjuvant therapy along with
antibiotic in clinical mastitis cases |
| Prevents
cross infection in udder |
Disinfects the whole udder area and
prevents cross infection |
| Superior
transdermal absorption |
Leads
to better penetration & spreadability
with quick onset of action & faster
recovery rate in clinical mastitis |
| Soothens
the teat and udder area |
prevents
dryness cracking of the udder and teat
area unlike other teat Sanitizers |
|
| |
|
|
| Indications: |
|
| |
|
|
| |
 |
In mastitis as a supportive
anti-inflammatory along with antibiotic therapy
to fasten the recovery rate |
| |
 |
In mastitis for quick relief
from inflammation and pain |
| |
 |
To prevent cross-infection
to other healthy quarter |
| |
 |
To prevent cracking of udder
& teat |
| |
|
|
|
|
| Dosage / Directions for
use: |
| |
|
|
|
|
| |
 |
Wisprec Spray is a topical
antimicrobial and anti-inflammatory to be used
in cases of clinical mastitis, |
| |
|
along with antimicrobials. |
| |
 |
Spray Wisprec in sufficient
quantity by placing the can in vertical position
to cover whole udder area |
| |
|
|
|
|
| |
|
|
|
 |
| |
|
|
|
|
| |
|
|
|
|
| |
|
| |
|
|
|
|
| |
| An
anti-inflammatory & antiseptic cream
for mastitis with high phytochemical actives |
|
|
|
| Presentation:
10g pouch & 25g Collapsible
tube |
| |
|
|
| |
|
| |
|
|
| |
Composition: |
|
| |
|
Wisprec Cream contains extracts
of : |
| |
|
|
|
|
| |
|
| Ingredient |
Marker
Compound |
Pharmacological
Action |
| |
|
|
| Tulasi |
Triterpenoids
(Ursolic acid, oleanolic acid) Phenolics(,Roasmarinic
acid, eugenol) |
Anti
bacterial, Anti inflammatory
|
| Bhutika |
Citral |
Anti-bacterial |
| Lamajjak |
Citronellal |
Anti-bacterial |
|
| |
|
|
|
|
| |
Field Trials: |
| |
|
The invitro efficacy of WISPREC
against various pathogenic species of bacteria
was evaluated and interpreted based on absence
of growth at minimum concentration of drug in
the agar |
| |
|
|
|
[ Read
more ...] |
| |
|
|
|
|
| |
Features & Benefits
: |
| |
|
| Features |
Benefits |
| |
|
|
Wisprec
is Topical Anti-Inflammatory |
Reduces
Inflammation, Pain & Swelling |
|
Wisprec
is Antiseptic |
Minimizes bacterial load on udder |
|
Wisprec
is Vulnerary |
Treats
teat cracks and teat injuries |
|
Wisprec
is Non irritant |
Soothens
the burning udder |
|
Wisprec
is cream based |
Spreads
easily & washable |
|
| |
|
|
|
|
| |
Indications: |
|
| |
|
|
|
|
| |
 |
In clinical mastitis, as
a supportive anti-inflammatory agent |
| |
 |
In udder oedema, to relieve
oedematous swelling |
| |
 |
To prevent mastitis in high
risk seasons by regular application on teat
orifice after each milking |
| |
 |
To treat sore teats and
teat cracks |
| |
 |
Highly effective as a multi-spectrum
dermatological cream for canines |
| |
|
|
|
|
| |
Dosage / Directions for
use:
Apply small quantity of Wisprec cream after
complete milking at the teat orifice to prevent
entry of mastitis causing
organisms
Clean the affected quarter in clinical mastitis
cases & apply Wisprec cream regularly twice/thrice
a day after each milking
|
| |
|
|
|
|
| |
|
Note :- for more details please
feel free to write us at pmd@naturalremedy.com |
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
 |
| |
|
|
|
|
| |
|
|
|
|